These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38075008)

  • 1. Editorial: Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways.
    Quarleri J; Delpino MV
    World J Hepatol; 2023 Nov; 15(11):1170-1173. PubMed ID: 38075008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics in liver diseases: A novel alternative for liver biopsy?
    Tanaka Y
    World J Hepatol; 2024 Jan; 16(1):12-16. PubMed ID: 38313246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways.
    Ferrasi AC; Lima SVG; Galvani AF; Delafiori J; Dias-Audibert FL; Catharino RR; Silva GF; Praxedes RR; Santos DB; Almeida DTM; Lima EO
    World J Hepatol; 2023 Nov; 15(11):1237-1249. PubMed ID: 38075010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage.
    Valva P; Ríos DA; De Matteo E; Preciado MV
    World J Gastroenterol; 2016 Jan; 22(4):1367-81. PubMed ID: 26819506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.
    Kim JH; Kim MN; Han KH; Kim SU
    Liver Int; 2015 Apr; 35(4):1103-15. PubMed ID: 24976523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kick-start for metabolomics in liver disease.
    Guerra-Ruiz A
    World J Hepatol; 2024 Sep; 16(9):1206-1210. PubMed ID: 39351520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.
    Piscaglia F; Salvatore V; Mulazzani L; Cantisani V; Schiavone C
    Ultraschall Med; 2016 Feb; 37(1):1-5. PubMed ID: 26871407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive fibrosis seromarkers as a predictor of liver fibrosis in chronic hepatitis C and/or non-alcoholic steatohepatitis.
    Ahmed L; Salama H; Ahmed R; Hamdy S; Al-Akel W; Shafi SA; Mahgoub A; Hareedy A; Fathy W
    Arab J Gastroenterol; 2009 Mar; 10(1):14-20. PubMed ID: 24842131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.
    Regev A; Berho M; Jeffers LJ; Milikowski C; Molina EG; Pyrsopoulos NT; Feng ZZ; Reddy KR; Schiff ER
    Am J Gastroenterol; 2002 Oct; 97(10):2614-8. PubMed ID: 12385448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy?
    Castera L; Bedossa P
    Liver Int; 2011 Jan; 31 Suppl 1():13-7. PubMed ID: 21205132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of portal venous index as a non-invasive method for diagnosing liver fibrosis in patients with chronic hepatitis C.
    Rocha HL; Diniz AL; Borges VF; Salomão FC
    Arq Gastroenterol; 2012; 49(1):14-8. PubMed ID: 22481681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the aspartate aminotransferase/platelet ratio index and enhanced liver fibrosis tests to detect significant fibrosis due to chronic hepatitis C.
    Petersen JR; Stevenson HL; Kasturi KS; Naniwadekar A; Parkes J; Cross R; Rosenberg WM; Xiao SY; Snyder N
    J Clin Gastroenterol; 2014 Apr; 48(4):370-6. PubMed ID: 24045284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels.
    Wang L; Li J; Yang K; Zhang H; Wang Q; Lv X; Guan S
    Medicine (Baltimore); 2020 Jun; 99(23):e20548. PubMed ID: 32502018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive and non-invasive monitoring of hepatitis C virus-induced liver fibrosis: alternatives or complements?
    Olga OZ; Nikolai DY
    Curr Pharm Biotechnol; 2003 Jun; 4(3):195-209. PubMed ID: 12769763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liver histology in hepatitis C: correlation with different biochemical and virological parameters].
    Lock G; Knöll A; Hauer S; Gelbmann CM; Hellerbrand C; Jilg W; Schölmerich J; Hartmann A
    Med Klin (Munich); 2000 Nov; 95(11):603-7. PubMed ID: 11143539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis C and liver fibrosis.
    Sebastiani G; Gkouvatsos K; Pantopoulos K
    World J Gastroenterol; 2014 Aug; 20(32):11033-53. PubMed ID: 25170193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.
    Sebastiani G; Alberti A
    World J Gastroenterol; 2006 Jun; 12(23):3682-94. PubMed ID: 16773685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient elastography--an alternative to liver biopsy in patients with chronic hepatitis C?
    Stanciu C; Trifan A; Cojocariu C
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):765-70. PubMed ID: 17438875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive assessment of inflammatory activity and fibrosis (grade and stage) in chronic hepatitis C infection.
    Verbaan H; Bondeson L; Eriksson S
    Scand J Gastroenterol; 1997 May; 32(5):494-9. PubMed ID: 9175214
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.